首页> 外文期刊>Medecine et maladies infectieuses >Update on human rabies in a dog- and fox-rabies-free country
【24h】

Update on human rabies in a dog- and fox-rabies-free country

机译:无狗和无狐狂犬病国家的人类狂犬病最新情况

获取原文
获取原文并翻译 | 示例
           

摘要

Rabies is responsible for 50,000 deaths per year worldwide. Mainland France has been officially freed from rabies in non-flying animals since 2001. Method: We wanted to provide an update on the French situation, using published data, and describe possible options since official guidelines are lacking. Results: Post-exposure prophylaxis (PEP) (early and careful cleaning and dressing of the wound, vaccination, and in case of high-risk exposure, injection of specific anti-rabies immunoglobulins) is known to be efficient except in rare cases. It is recommended after grade II contact (+specific immunoglobulins in immunodepressed patients), or grade III contact (vaccination. +. immunoglobulins). Discussion: Mainland France being rabies-free, 3 options may be considered in case of bite by a dog or a cat that cannot be monitored in France: (a) consider the risk of rabies as null, so no PEP should be administrated, whatever the severity of bites; (b) consider there is a weak but lethal risk, so the international recommendations should be applied, using immunoglobulins in some cases; (c) consider that the risk is extremely low but cannot be excluded, and that the patient should be vaccinated to be protected, but without adding immunoglobulins (whether in case of grade II or III bites). Conclusion: There are no national guidelines for rabies in France, and so the physician managing the patient is the one who will decide to treat or not.
机译:狂犬病每年在全球造成50,000人死亡。自2001年以来,法国大陆已正式摆脱非飞行动物的狂犬病。方法:由于缺乏官方指南,我们希望利用已发布的数据提供法国情况的最新信息,并描述可能的选择。结果:众所周知,暴露后预防(PEP)(及早,仔细地清洁和包扎伤口,接种疫苗以及在高风险暴露的情况下,注射特定的抗狂犬病免疫球蛋白)是有效的,除了极少数情况下。建议在II级接触后(+在免疫低下的患者中使用特异性免疫球蛋白)或III级接触后(接种+。免疫球蛋白)。讨论:法国大陆没有狂犬病,如果在法国无法监测的狗或猫咬人,可以考虑以下三种选择:(a)认为狂犬病的风险为零,因此,不应该实施PEP叮咬的严重程度; (b)认为存在微弱但致命的风险,因此应采用国际建议,在某些情况下使用免疫球蛋白; (c)认为风险极低,但不能排除,应该给患者接种疫苗以得到保护,但不添加免疫球蛋白(无论是II级还是III级咬伤)。结论:法国没有国家关于狂犬病的指南,因此管理患者的医生是决定是否治疗的人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号